BDX ファイナンス： Becton Dickinson and Co AI分析



財務状況

BDX 財務

Becton Dickinson and Co

$143.92

2.28%

$3.2

終値： Jun 23, 16:00:00 GMT-4

$143.94

0.01%

$0.02

アフターマーケット：Jun 23, 19:41:54 GMT-4

概要予測収入配当財務状況

主要データ

前終値

$140.71

始値

$142.55

当日レンジ

$141.25 - $145.59

52週レンジ

$127.59 - $187.35

取引高

平均取引高

2.9M

配当利回り

2.86%

1株当たり利益(TTM)

3.94

時価総額

$39.6B

BDXとは何ですか？

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.

特徴

Markets

News

利用規約プライバシーポリシー

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
収入	21,366	4,714	5,252	5,891	5,509	5,272
収益成長率（YoY）	2%	-11%	2%	8%	10%	5%
収益のコスト	11,326	2,518	2,841	3,092	2,875	2,939
売上総利益	10,040	2,196	2,411	2,799	2,634	2,333
販売、一般および管理	5,292	1,213	1,393	1,366	1,320	1,273
研究開発	1,174	249	306	322	297	302
運営費用	6,450	1,436	1,710	1,684	1,620	1,579
その他の非営業収入（費用）	46	111	-10	-23	-32	-37
税引前利益	1,645	39	393	510	703	363
所得税費	233	76	11	17	129	55
純利益	1,138	-311	382	493	574	308
純利益成長率	-25%	-200.99%	26%	17%	18%	-43%
流通済み株式数（希薄化後）	280.64	280.64	285.84	287.95	287.22	287.73
株式変動（前年比）	-2%	-2%	-2%	-1%	-1%	-1%
EPS（希薄化）	4.05	-1.1	1.33	1.71	1.99	1.07
EPS成長率	-23%	-202.99%	28%	18%	19%	-42%
フリーキャッシュフロー	3,069	473	549	1,002	1,045	35
1株当たりフリーキャッシュフロー	--	--	--	--	--	--
粗利益	46.99%	46.58%	45.9%	47.51%	47.81%	44.25%
営業利益率	16.8%	16.12%	13.34%	18.92%	18.4%	14.3%
利益率	5.32%	-6.59%	7.27%	8.36%	10.41%	5.84%
フリーキャッシュフロー利益率	14.36%	10.03%	10.45%	17%	18.96%	0.66%
EBITDA	5,971	1,280	1,315	1,744	1,632	1,362
EBITDAマージン	27.94%	27.15%	25.03%	29.6%	29.62%	25.83%
D&A による EBITDA	2,381	520	614	629	618	608
営業利益	3,590	760	701	1,115	1,014	754
営業利益率	16.8%	16.12%	13.34%	18.92%	18.4%	14.3%
実効税率	14.16%	194.87%	2.79%	3.33%	18.34%	15.15%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

収入

21,366

4,714

5,252

5,891

5,509

5,272

収益成長率（YoY）

-11%

10%

収益のコスト

11,326

2,518

2,841

3,092

2,875

2,939

売上総利益

10,040

2,196

2,411

2,799

2,634

2,333

販売、一般および管理

5,292

1,213

1,393

1,366

1,320

1,273

研究開発

1,174

249

306

322

297

302

運営費用

6,450

1,436

1,710

1,684

1,620

1,579

その他の非営業収入（費用）

111

-10

-23

-32

-37

税引前利益

1,645

393

510

703

363

所得税費

233

129

純利益

1,138

-311

382

493

574

308

純利益成長率

-25%

-200.99%

26%

17%

18%

-43%

流通済み株式数（希薄化後）

280.64

285.84

287.95

287.22

287.73

株式変動（前年比）

-2%

-1%

EPS（希薄化）

4.05

-1.1

1.33

1.71

1.99

1.07

EPS成長率

-23%

-202.99%

28%

18%

19%

-42%

フリーキャッシュフロー

3,069

473

549

1,002

1,045

1株当たりフリーキャッシュフロー

粗利益

46.99%

46.58%

45.9%

47.51%

47.81%

44.25%

営業利益率

16.8%

16.12%

13.34%

18.92%

18.4%

14.3%

利益率

5.32%

-6.59%

7.27%

8.36%

10.41%

5.84%

フリーキャッシュフロー利益率

14.36%

10.03%

10.45%

17%

18.96%

0.66%

EBITDA

5,971

1,280

1,315

1,744

1,632

1,362

EBITDAマージン

27.94%

27.15%

25.03%

29.6%

29.62%

25.83%

D&A による EBITDA

2,381

520

614

629

618

608

営業利益

3,590

760

701

1,115

1,014

754

営業利益率

16.8%

16.12%

13.34%

18.92%

18.4%

14.3%

実効税率

14.16%

194.87%

2.79%

3.33%

18.34%

15.15%

Follow-Up Questions

Becton Dickinson and Co의 주요 재무제표는 무엇인가요?



최신 재무제표(Form-10K)에 따르면, Becton Dickinson and Co의 총 자산은 $0이며, 순損失입니다.

BDX의 주요 재무 비율은 무엇인가요?



Becton Dickinson and Co의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.

Becton Dickinson and Co의 매출은 부문 또는 지역별로 어떻게 나뉘나요?



Becton Dickinson and Co の最大収益セグメントは Medication Delivery Solutions で、最新の利益発表における収益は 4,575,000,000 です。地域別に見ると、United States が Becton Dickinson and Co の主要市場であり、収益は 12,790,000,000 です。

Becton Dickinson and Co은 수익성이 있나요?



いいえ, 최신 재무제표에 따르면 Becton Dickinson and Co의 순損失은 $0입니다.

Becton Dickinson and Co에 부채가 있나요?



いいえ, Becton Dickinson and Co의 부채는 0입니다.

Becton Dickinson and Co의 발행 주식은 몇 주인가요?



Becton Dickinson and Co의 총 발행 주식은 0주입니다.

Becton Dickinson and Co (BDX) 財務

BDX 株価推移チャート

主要データ

前終値

始値

当日レンジ

52週レンジ

取引高

平均取引高

配当利回り

1株当たり利益(TTM)

時価総額

BDXとは何ですか？

Becton Dickinson and Co (BDX) 財務

BDX 株価推移チャート

主要データ

前終値

始値

当日レンジ

52週レンジ

取引高

平均取引高

配当利回り

1株当たり利益(TTM)

時価総額

BDXとは何ですか？

BDX 収入

Follow-Up Questions

Becton Dickinson and Co의 주요 재무제표는 무엇인가요?

BDX의 주요 재무 비율은 무엇인가요?

Becton Dickinson and Co의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Becton Dickinson and Co은 수익성이 있나요?

Becton Dickinson and Co에 부채가 있나요?

Becton Dickinson and Co의 발행 주식은 몇 주인가요?